Capillary Leak Index Versus Conventional Biomarkers in Predicting Sepsis-Related Outcomes
1 other identifier
observational
100
1 country
1
Brief Summary
This study aims to evaluate the prognostic significance of CLI in predicting 28-day mortality and other outcomes in critically ill patients who develop post-operative abdominal sepsis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2025
CompletedFirst Posted
Study publicly available on registry
November 18, 2025
CompletedStudy Start
First participant enrolled
December 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 30, 2026
November 18, 2025
November 1, 2025
10 months
November 14, 2025
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
all-cause mortality
From 1-10-2025 to 1-10-2026
Study Arms (1)
adult patients admitted to the ICU with post-operative secondary peritonitis requiring an ICU stay o
Interventions
Blood samples will be collected at three time points: within 1-2 hours of ICU admission (Day 0), Day 1, Day 2 and Day 7, to monitor trends in CLI and conventional biomarkers during the ICU stay. • CR
Eligibility Criteria
adult patients admitted to the ICU with post-operative secondary peritonitis requiring an ICU stay of at least 48 hours will be enrolled.
You may qualify if:
- Age ≥ 18 years.
- Postoperative secondary peritonitis requiring ICU admission, with clinical evidence of:
- Diffuse or localized abdominal pain/tenderness. Peritoneal signs (e.g., guarding, rigidity, rebound tenderness). Imaging or intraoperative confirmation of purulent/exudative intra-abdominal fluid.
- Systemic inflammation (e.g., fever, leukocytosis, or vasopressor requirement). Sepsis diagnosis per Sepsis-3 criteria: Suspected/confirmed infection with acute increase in SOFA score ≥2 points (6).
- Anticipated ICU stay ≥48 hours postoperatively.
You may not qualify if:
- Pregnancy
- Advanced liver disease (Child-Pugh class B or C) that might independently affect albumin levels
- Advanced kidney disease (CKD stage 4 or 5) or patients on chronic dialysis
- Expected mortality within 48 hours of ICU admission
- Patients with primary peritonitis or tertiary peritonitis
- Immunocompromised patients (e.g., on chronic immunosuppressive therapy, solid organ transplant recipients, patients with HIV and CD4 count \<200/mm³)
- Patients with pre-existing systemic inflammatory diseases that might affect baseline CRP levels
- Patients participating in interventional trials that might affect outcomes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Benha Universitylead
Study Sites (1)
Benha University Hospital
Banhā, Qalyubia Governorate, 13511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
November 14, 2025
First Posted
November 18, 2025
Study Start
December 10, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 30, 2026
Last Updated
November 18, 2025
Record last verified: 2025-11